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Introduction
Pain is known to be an unpleasant sensory and 
emotional experience associated with potential 
and actual tissue damage.[1] Despite major 
advances of postoperative pain management,[2] 
it continues to be a significant problem 
for many patients after major surgery.[3] 
Sternotomy, rib retraction, conduit harvest, and 
drain tubes are some of the sources of pain in 
cardiac surgery.[4] Therefore, postcardiothoracic 
surgery, the role of planned pain management 
is crucial for early mobilization, decreasing 
pulmonary complications such as atelectasis, 
shortening the hospital length of stay (LOS),[5] 
and reducing cardiovascular and endocrine 
complications.[6]
Regional anesthetic infiltrations and 
subcutaneous infusions (pain busters) 
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Abstract
Cardiac surgery induces severe postoperative pain and impairment of pulmonary function, 
increases the length of stay (LOS) in hospital, and increases mortality and morbidity; therefore, 
evaluation of the evidence is needed to assess the comparative benefits of different techniques of 
pain management, to guide clinical practice, and to identify areas of further research. A systematic 
search of the Cochrane Central Register of Controlled Trials, DARE database, Joanna Briggs 
Institute, Google scholar, PUBMED, MEDLINE, EMBASE, Academic OneFile, SCOPUS, and 
Academic search premier was conducted retrieving 1875 articles. This was for pain management 
postcardiac surgery in intensive care. Four hundred and seventy‑one article titles and 266 abstracts 
screened, 52 full text articles retrieved for critical appraisal, and ten studies were included including 
511 patients. Postoperative pain (patient reported), complications, and LOS in intensive care and 
the hospital were evaluated. Anesthetic infiltrations and intercostal or parasternal blocks are 
recommended the immediate postoperative period (4–6 h), and patient‑controlled analgesia (PCA) 
and local subcutaneous anesthetic infusions are recommended immediate postoperative and 24–72 h 
postcardiac surgery. However, the use of mixed techniques, that is, PCA with opioids and local 
anesthetic subcutaneous infusions might be the way to go in pain management postcardiac surgery 
to avoid oversedation and severe nausea and vomiting from the narcotics. Adequate studies in the 
use of ketamine for pain management postcardiac surgery need to be done and it should be used 
cautiously.
Keywords: “Pain” management, pain guidelines, cardiac surgery, cardiothoracic intensive care, 
critical care, intensive care unit, local anesthetic subcutaneous infusions, meta‑analyses, open heart 
surgery, pain, pain busters, pain protocols, paravertebral blocks, patient‑controlled analgesia, 
postcardiac surgery, randomized controlled trials, sternotomy
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around the wound are some of the pain 
management techniques which carry the 
advantages of providing superior analgesia 
and avoiding some of the adverse effects 
of systemic opioid treatment.[7] However, 
opioid infusions and patient‑controlled 
analgesia (PCA) remain the primary and 
most commonly used pharmacological 
therapies immediate postoperative 
after cardiac surgery in Intensive Care 
Units (ICUs).[8]
Epidural analgesia or blocks for pain 
management will not be considered in this 
review because of the controversy and 
contraindication that surrounds its use in 
cardiac patients including complications 
such as hematoma due to perioperative 
coagulation.[9] Mazzeffi and Khelemsky[8] 
stated that, “even if the risk of developing a 
hematoma in cardiac surgery is known to be 
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1 in 12000, due to the severity of the consequences related 
to epidural hematomas, this technique remains underused 
in postoperative pain management in cardiac surgery.”
The efficacy of ketamine and opioid infusions, paravertebral 
blocks, PCA, subcutaneous nurse‑administered opioids, 
ropivacaine/bupivacaine local continuous subcutaneous 
infusions, and infiltrations in cardiac surgery have been 
assessed in this review of randomized controlled trials. 
This is in relation to postoperative pain management, early 
mobilization, and LOS in intensive care and hospital in 
general.
Materials and Methods
Selection criteria
Inclusion and exclusion
Included were randomized controlled trial articles for 
adults eighteen years and over post cardiac surgery. These 
included the use of subcutaneous anesthetic infusions, 
paravertebral blocks/infiltrations, PCAs, Ketamine/ opioid 
infusions and nurse administered subcutaneous (NASC) 
opioids for pain management in Intensive care. There was 
no restriction to opioids or anesthetic medications used 
were made. Included studies were all postcardiac surgery 
articles, including valve repair or replacement and coronary 
artery bypass and grafts in intensive care.
All studies using epidural analgesia or blocks for pain 
management postcardiac surgery were excluded from the 
study.
Search strategy
Two independent reviewers searched the Cochrane Central 
Register of controlled trials, Joanna Briggs Institute and the 
Google scholar. EMBASE, DARE, PUBMED, MEDLINE 
and SCOPUS databases were also searched using the 
keywords above.
Critical appraisal tools
The JBI critical appraisal form for randomized controlled 
trials was used. Eligible studies were graded using 
the following scoring system: First, if there was true 
randomization used for assignment of participants to the 
treatment groups,[1] if the allocation was concealed,[2] and if 
the outcome assessors were blind to the assignment.[6] The 
description of an appropriate method of double blinding 
was graded as follows: yes, no, and unclear. The studies 
had to have a YES on criteria 1, 2, and 6 to qualify. The 
flow diagram is included below and shows how the search 
strategy was done and articles included and excluded.
Data extraction
The JBI data extraction form was used as a model for 
data extraction but was modified to the specific need of 
information for this specific systematic review. Any data on 
patient‑reported pain using visual analog scale (VAS) and 
numerical rating scores were extracted from the studies. 
Specific outcomes that were extracted included pain scores 
at rest and with activity including coughing and need for 
rescue medication. The complications as described in the 
outcome measures were indicated where applicable. Data on 
LOS in ICU and in hospital were extracted where recorded.
Analysis of outcomes
Information from each included study was recorded 
in data tables [Table 1]. The primary outcomes were 
patient‑reported pain, LOS, and complications due to 
inadequate pain management (atelectasis, pneumonia, 
wound infection, and increase in mortality/morbidity) 
where reported. Means and standard deviations (SDs) were 
extracted from the text, tables, or graphs within the studies. 
Quantitative analysis was limited by heterogeneity in study 
designs, and the subject numbers were small. The limited 
number of randomized controlled studies led to a narrative 
synthesis of the systematic review.
Results
Database searches yielded 1875 articles. Further screening 
yielded 873 articles in which inclusion and exclusion 
titles and abstracts reduced the number of articles to 52; 
52 were retrieved, 13 of which were noncardiac articles, 4 
were reviews, 8 were cardiac but nonrandomized controlled 
trials, and 17 articles failed to meet the criteria during 
data extraction. Ten articles were included in this study. 
Randomized clinical trials enrolling a total of 511 patients 
were included for the final narrative analysis [Figure 1]. 
Flow diagram for pain management postcardiac surgery 
shows the search criteria.
Local infiltrations and parasternal blocks
Parasternal block and local anesthetic infiltrations 
with levobupivacaine versus Saline (P)[10] showed 
significantly less use of morphine as a rescue drug in the 
levobupivacaine (LB) group (P = 0.02) compared to the P 
group after surgery over the 24 h period. Zero percentage 
of the LB group needed rescue medication versus 44.4% of 
the P group. The VAS scores were not significantly different 
at rest and when coughing, statistically as indicated in 
Figure 2a and b below. Alveolar‑arterial oxygen gradient 
and partial oxygen were measured and were significantly 
better in the LB group at the time of extubation and better 
throughout the first 24 h period.
Table 1: Intravenous patient‑controlled analgesia 
consumption
Intravenous patient‑controlled analgesia consumption
Bupivacaine (n=19) Sham group (n=19) P
24 h 26.8±11.0 36.3±17.3 0.095
48 h 56.4±22.4 67.6±30.3 0.092
72 h 70.5±26.4 91.4±40.7 0.117
IV PCA consumption. Chiu et al., 2008[15]
Figure 1: Pain management post cardiac surgery. Flowchart describing 
the search criteria
Figure 2: Verbal analog scores for pain at rest (a) and with cough (b) on a 
standard 0 to 10 scale over the first 24 h after surgery. Values are a mean 
± standard deviation. (McDonald et al. 2005)[16]
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Parasternal intercostal block with ropivacaine for pain 
management after  cardiac surgery, was used in a double 
blind randomized controlled trial with saline.[11] The 
ropivacaine group had almost 50% visual analogue pain 
scores less than those in the saline group with a mean of 
29.5, SD = 24.3 versus 53.2 = 24.1, ropivacaine versus saline 
respectively, P = 0.001. Numerical rating scale scores were 
similarly significantly less for patients in the ropivacaine 
group at extubation with a mean = 2.7 (SD = 1.6) versus 5.2 
(SD = 2.0), respectively; (95% CI: −3.3 to −1.7, P = 0.01). 
The use of morphine PCA in the ropivacaine patients was 
approximately 50% less for the first 12 h after surgery (12.0 
[SD = 5.4] vs. 23.2 [SD = 8.3] total morphine equivalent in 
milligrams R vs. S respectively; P < 0.001 [95% CI, −14.3 
to −8.1]) as indicated in the graph [Figure 3].
The Efficacy of parasternal injection of bupivacaine 
on postoperative pain for early extubation in patients 
undergoing coronary artery bypass surgery was assessed. 
The VAS pain score in the bupivacaine group remained 
0–3 with a mean (1.38 ± 1.19) and none of the patients 
required rescue pain medication, while in the placebo 
group, the mean of 6.13 ± 2.92 which was very significant, 
the difference in the mean VAS between the two groups 
(P = 0.001), rescue medication was required in 8 (53.3%) 
whereas non from Bupivacaine.
Partial oxygen (PaO2) showed a trend to be higher in 
the Bupivacaine group with a mean of 208.23 ± 42.57, 
whereas in the placebo, a mean was 126.40 ± 23.15. 
These results reflected the respiratory comfort and ease 
of vital capacity whose difference was statistically 
significant (P < 0.001).
Local subcutaneous infusions
Results of a randomized double blind clinical trial of 
ropivacaine (0.2%) versus saline showed improved pain 
control after cardiac surgery. Patients in the ropivacaine 
group reported significantly less pain than the saline group 
with a mean overall VAS pain score significantly lower than 
the saline group (1.6 vs. 2.6, P = 0.005). This also reflected 
in the total narcotic use where ropivacaine versus the 
control group 47.3 versus 78.7 mg (P = 0.038), respectively, 
and day 2 postoperatively (15.5 vs. 29.4 mg, P = 0.025). 
The mean LOS for the patients in the ropivacaine group 
was 5.2± (1.3) days, with a range of 3–7 days, whereas the 
mean LOS in the control group was 8.2 ± 7.9 days with a 
range of 4–39 days. There was a trend toward improvement 
in pulmonary function in the ropivacaine group.
The analgesic effects of a bilateral sternal infusion of 
ropivacaine after cardiac surgery[14] in the first 48 hours 
proved lower pain scores in the ropivacaine group during 
mobilization (P = 0.0004) and at rest (P = 0.0006), 
and the analgesic effects were mostly apparent on day 2 
postsurgery. The amount of morphine consumption reduced 
in the ropivacaine group and their satisfaction and 
rehabilitation improved; however, no effects were noted 
on respiratory outcomes. Clinical tolerance and comfort 
were also better in the ropivacaine group. The ropivacaine 
plasma levels remained beneath the mean level observed 
for occurrence of neurologic symptoms.
Local infusion of bupivacaine combined with patient 
controlled analgesia provides better pain relief than 
intravenous patient controlled analgesia alone in patients 
undergoing a minimally invasive cardiac surgery.[15] In 
this study, there were no differences in time to extubation, 
ICU, or hospital stay. There appeared to be a trend in 
a
b
Figure 3: Consumption of patient-controlled analgesia Morphine in the 12 
h period (Barr et al.)
Table 2: Morphine consumption and recovery times 
after surgery
Outcomes Group B (n=19) Group C (n=18) P
Morphine 
consumption over the 
48 h (mg)
8.6±0.94 18.83±3.4 0.02
Extubation time (min) 117±10* 195±19 0.03
ICU stay (h) 56.1±30 55.4±22 0.36
Hospital stay (days) 5.5±1.2 5.7±1.6 0.3
Nasr et al., 2015. B: Bupivacaine, C: Saline group, ICU: Intensive 
Care Unit
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reduction in PCA requirements when bupivacaine was 
infused into the wound. The Sham infusion group had 
greater and more persistent pain than the bupivacaine 
infusion group even at 24 h, 48 h, and at 3 months after 
the operation  [Table 2].
The analgesic efficacy of continuous paesternal bupivacaine 
infusion through a single catheter after cardiac surgery[16] 
proved to reduce pain scores in the bupivacaine group. 
The overall morphine requirements over the first 48 h in 
ICU were significantly less in group B than group C, 
mean = 8.6 mg ± (0.94) vs. 18.83 mg ± (3.4), respectively, 
P = 0.02. The mean VAS scores were also significantly less 
in Group B than Group C at most time points.
The time to extubation was shorter in Group B compared 
to Group C, with a mean of 117 min (±10) versus 195 min 
± (19), respectively, P = 0.03. However, there was no 
statistical difference between the two groups in the ICU 
and hospital stay duration. The respiratory parameters such 
as PaO2/FiO2 and partial carbon‑dioxide were better in 
Group B at extubation, 6 h, 12 h, and 24 h mark compared 
to Group C [Table 3].
Ketamine infusions
S (+) ketamine versus a placebo as an analgesic adjunct 
proved to reduce opioid consumption after cardiac 
surgery.[17] During the first 48h postoperatively, the 
consumption of oxycodone in the S (+) ketamine group 
was less, mean = 103 mg ± (44) compared to mean of 
125 mg ± (45) in the placebo group: mean difference 
was 22 mg and 95% confidence interval (CI) for the 
difference of 3–40 mg, P = 0.023. The time after tracheal 
extubation to the first dose of oxycodone with PCA was 
longer in the S (+) Ketamine group 134 min ± (125) and 
101 min ± (197) respectively, P = 0.013. The VAS pain 
scores during the 48 h period were comparable both at 
rest and during a deep breath with no statistical difference. 
When asked if they could use the same type of analgesia, 
41 (93%) of the 44 patients in the S (+) Ketamine group 
and 41 (89%) of the 46 in the placebo group replied 
affirmatively.
Pulmonary function tests, mobilization tests, walking 
exercises with physiotherapists, maximal oxygen 
capacity (VO2) and Vco2, and postoperative PCO2 levels 
were higher in the placebo group than the in the S (+) 
Ketamine group (P = 0.021).
Patient‑controlled analgesia and opioids
Patient controlled analgesia of remifentanil(RM) versus 
morphine (M)[18] post cardiac surgery, did not show a 
significant difference in effectiveness. After 24 h of PCA 
use, no statistically significant difference in both groups 
in pain management. The LOS of the patients in ICU 
was 46.83± (4.6) h for remifentanil (RM) group and 
45.44± (5.6) h for M group. The overall LOS in hospital 
after the operation was 5.2± (1) days versus 5.1± (1) 
days, respectively. Each group had 14% of the patients 
present with atelectasis postoperatively which was 
treated with chest physiotherapy. However, the overall 
effectiveness was rated very good or good in 87% by 
RM group compared to 72% of the patients in the M 
group.
Nurse administered subcutaneous morphine is a 
satisfactory alternative to intravenous patient controlled 
analgesia of morphine after cardiac surgery.[19] There 
was no statistically significant difference found between 
the two groups in any of the variables measured. Median 
VAS pain scores at rest and with movement; on day 
1, it was 0 and 3 in the NASC and 0 and 2.5 in the 
intravenous (IV) PCA, and on day 2, it was 0 and 2.5 in 
NASC group and 0 and 2 in the IV PCA group. Unblind 
physiotherapists scored the success of mobilization and 
the difficulty the patients had in obtaining additional 
analgesia before physiotherapy for the two groups. For 
the IV PCA group (VAS scale 1–10), it was 8 (6–9) and 
7 (7–8) for the NASC group. Total morphine administered 
postoperatively was 42.7 ± 32.4 mg in the IV PCA group 
and 53.3 ± 29.3 mg in the NASC group. Morphine 
consumption through IV PCA or NASC in the first 24 h 
after extubation was 33 ± 22 mg and 37 ± 20 mg in the 
IV PCA group and NASC group, respectively.
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Contd...
Table 3: Demonstrates the patient demographics employed by the included studies, the comparisons used and the 
recorded and reported outcomes
Included 
Studies
Population Patient Demographics: sex (S), age 
(A), weight range body surface area 
(BSA) or body mass index (BMI) 
whichever is available
Comparisons Main Outcomes Patient 
reported pain (VAS) scores, 
length of stay in ICU & 
hospital and respiratory/
immobility complicationsControl group Treatment group 
McDonald 
et al. 
2005[10]
Patients 18‑80 years 
of age undergoing 
either single valve 
replacement or coronary 
artery bypass grafting 
with or without 
cardiopulmonary bypass 
without complications
Placebo=9
S (m/f):8/1
A: 64±11
BMI: 28.1±4.2
Levobupivacaine=8
8/0
61±9
29.7±1.9
54mls of 0.25% 
levobupivacaine 
(LB) with 1:400000 
epinephrine or 
54mls normal saline 
with no epinephrine 
added as a 
parasternal block.
Less morphine used in 
treatment group‑20.8±6.2 vs. 
33.2±10.9 (control) Reported 
VAS scores not significantly 
different. Better oxygenation 
at time of extubation in the LB 
group.
Barr et al. 
2007[11]
Patients to be extubated 
within 6hrs post 
primary non‑emergency 
multi‑vessel CABG on 
or off cardiopulmonary 
bypass, aortic and mitral 
valve replacements 
or repair, atrial septal 
defect repair
N=Normal 
saline (45)
S (m/f):35/8
A: 60±15
BSA (Mean): 
1.9 (1.8‑2.0)
Ropivacaine (43) 
34/11
62±18
1.9 (1.9‑2.0)
0.75% ropivacaine 
via parasternal 
intercostal block 
or Saline before 
closure of sternal 
wound
At extubation parasternal block 
patients with ropivacaine had 
visual analogue and numerical 
rating sores approximately 50% 
less than the normal saline group 
Over the first 24 hrs. Low oxygen 
saturation was significantly more 
in the saline group. No difference 
in the incidence of postoperative 
pneumonia between the groups.
Rahman 
et al. 
2016[12]
Female or male, adults 
undergoing first time for 
isolated coronary artery 
bypass surgery.
Without complications
Placebo (normal 
saline) =15
S (m/f):9/6
A: no age
W: no weight or 
height specified
H:
Bupivacaine 0.5% 
=13
S (M/F): 8/5
Bupivacaine 
0.5%@2mg/kg and 
normal saline 0.9% 
infiltrated in the 
parasternal wound
The VAS remained at a mean of 
1.38±1.19 in the Bupivacaine (B) 
group, while 6.13±2.92 in the 
placebo group. Pao2 remained 
high in the B and lower in the 
placebo group. ICU or hospital 
stay was not reported
Dowling 
et al. 
2003[13]
Patients undergoing 
elective CABG alone 
or combined with 
laser trans‑myocardial 
revascularization
Normal saline
n=19
S (m/f):14/5
A: 56±8
BSA: (95%): 
2.1 (2.0‑2.2)
Ropivacaine 0.2%
n=16
13/3
55±11
0.2% ropivacaine 
at 4mls/hr. with 
narcotic PCA and 
Normal saline with 
narcotic PCA
The mean overall pain scores for 
the ropivacaine were significantly 
less than those for normal saline 
(1.6 vs. 2.6). Length of stay 
5.2 days for ropivacaine vs. 
8.2 days for normal saline group. 
No difference in assessment of 
pulmonary function.
Eljezi 
et al. 
2012[14]
18‑90 year old 
scheduled for open heart 
surgery with sternotomy 
for valve replacement 
or CABG with 
cardiopulmonary bypass 
with no complications
N=placebo (19)
S (m/f):16/3
A: 64±12
W: 76±14
H: 168±10
Ropivacaine 0.2%
n= (20)
S (m/f) not 
indicated
68±13
77±9
170±9
4mls/hr. of 0.2% 
Ropivacaine and 
0.9% Normal saline
VAS: pain scores lower in 
the ropivacaine group during 
mobilization. No effects on 
respiratory functions, quality 
of rehabilitation was improved 
except on respiratory outcomes. 
ICU and hospital stay were not 
reported
Chiu et al. 
2008[15]
Adult Patients 
undergoing minimally 
invasive cardiac surgery 
without complications
N Saline=19
S (m/f): 12/7
A: 57.4±15.2
W: 63.6±12.9
H: 1.59±0.08
Bupivacaine 0.15% 
=19
S (M/F): 13/6
59.7±13.8
63±10.4
1.62±0.10
0.15%bupivacaine 
@ 2mls/hr. and 
Normal saline
No differences in time of 
extubation, ICU or hospital 
stay. The bupivacaine group had 
reduced pain in the first 48hrs 
including 24hrs after cessation of 
the infusion.
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Discussion
Major findings
Use of opioids analgesics alone postcardiac surgery is 
an acceptable and established way of pain management 
worldwide.[20] We performed a systematic review of 
randomized controlled trials and found that parasternal and 
intercostal blocks, local anesthetic infiltrations, and local 
anesthetic continuous infusions when used with background 
of opioid PCA appeared to be effective pain management in 
patients postcardiac surgery and improved patient outcomes.
Application of anesthetics directly to wounds provides 
analgesia by blocking transmission of pain from nociceptive 
afferents in the wound surface and by inhibiting local 
inflammatory response to injury, thereby reducing the 
release of inflammatory mediators from neutrophils and 
decreasing edema formation.[21]
Infiltrations and parasternal blocks and continuous 
subcutaneous anesthetic infusions
The local infiltrations and parasternal blocks[10‑12] appeared 
to be much more effective in the first 4–6 up to 24 h 
postoperatively. This result is in line with previous systematic 
reviews conducted on evaluating regional techniques for 
postthoracotomy analgesia.[22] Previous systematic reviews were 
not able to detect the appreciable benefit from single injection 
of local anesthetics in abdominal operation or laparoscopy.[23,24]
The continuous subcutaneous anesthetic infusions[13‑16] were 
effective much longer and associated with reduced LOS as 
indicated in previous review.[21]
Table 3: Contd...
Included 
Studies
Population Patient Demographics: sex (S), age 
(A), weight range body surface area 
(BSA) or body mass index (BMI) 
whichever is available
Comparisons Main Outcomes Patient 
reported pain (VAS) scores, 
length of stay in ICU & 
hospital and respiratory/
immobility complicationsControl group Treatment group 
Nasr et al. 
2015[16]
45‑60 years scheduled 
for open heart surgery 
for CABG with CPB 
without complications
Saline solution=18
S (m/f): 10/8
A: 53±5.8
W: H
Bupivacaine 
0.25%‑19
S (M/F): 11/8
54±4.5
5ml/hr. bupivacaine 
0.25% and normal 
saline
Lower post‑operative pain scores, 
better respiratory parameters, 
shorter extubation times with 
no incidence of wound infection 
in the Bupivacaine group; no 
differences in ICU or hospital 
stay duration
Lahtinen 
et al. 
2004[17]
Adult Pts scheduled for 
CABG with CPB and 
younger than 70 years 
of age
Non complicated
Normal saline
n= (46)
S (m/f):43/3
A: 58±7
W: 83±10
H: 173±6
S(+) Ketamine
N= (44)
37/7
59±5
85±13
172±8
S (+) 
Ketamine‑75µg/
kg bolus+infusion 
of 1.25µg/kg/min 
and normal saline 
infusion
VAS scores were comparable in 
the first 48hrs both at rest and 
during deep breaths. Tracheal 
extubation times were similar, 
PCo2 levels were higher in the 
placebo group. Respiratory 
effects and length of stay was not 
reported.
Baltali 
et al. 
2009[18]
Adult Cardiac surgical 
patients undergoing 
CABG non‑complicated
N=R (29)
S (m/f): 21/8
A: 57±8
W: 80±11
H:
N=M (29)
22/7
58±8
79±13
Remifentanil 
0.05µg/kg/min, 
0.25µg bolus and 
Morphine 1mg 
bolus, 0.3mg/hr. 
PCA
On coughing the NRS values 
were significantly lower in 
Remifentanil than Morphine, 
not much difference in overall 
effectiveness. 4 patients 
in each group developed 
atelectasis, which needed routine 
physiotherapy. ICU or Hospital 
stay was not reported
Munro 
et al. 
1998[19]
All patients scheduled 
for non‑emergency 
cardiac surgery without 
complications
IV PCA of 
Morphine‑39
S (m/f):32/7
A: 61.1±12
W: 81±11.9
H: not recorded
NA SC 
Morphine‑41
S (M/F): 32/9
58.7±10.1
84.4±12.8
H:
IV PCA with 
morphine 1mg 
bolus, 6 min 
lock out and 
10mg/h limit, and 
nurse‑administered 
subcutaneous 
morphine 0‑7.5mg 
given every 1‑2hrs
VAS scores at rest and with 
movement, daily verbal pain 
relief scores and side effect 
profiles were not significantly 
different. Hospital or ICU stay 
was not reported
S: sex, M/ F ‑Male or female, W: weight, H: height, VAS: visual analogue scale, ICU: Intensive Care Unit, IV PCA; intravenous Patient 
controlled analgesia, NA SC: nurse administered subcutaneous; BMI‑ body mass index, BSA‑ body surface area, CABG‑coronary artery 
bypass graft, CPB‑cardiopulmonary bypass, R‑ Remifentanyl, M‑Morphine
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In the local anesthetic groups, whether infiltrated, nerve 
block, or subcutaneous infusions, all patients in the 
control and treatment groups used opioids to cover other 
discomforts associated with the operation and ICU 
admission. The use of both local anesthetic infusions with 
PCA[15] demonstrated superior analgesia to PCA alone in 
reducing pain post minimally invasive cardiac surgery. 
This was also demonstrated in other studies[13,14,16,20,25] and 
led to the reduction in the use of opioids and consequent 
reductions in hospital stay. Nasr et al.[16] also demonstrated 
early extubation in the bupivacaine group with better 
respiratory parameters as indicated by the arterial blood 
gases (ABG) analyses at the time of extubation and the 
subsequent readings compared to the control group. On 
the contrary, Eljezi et al.[14] did not demonstrate any 
improvement in the respiratory function with improvement 
in analgesia in their study group. This could have been due 
to the use of different parameters of assessing respiratory 
functions, for example, ABGs versus pulmonary function 
tests. This review also demonstrates why it is important 
to consider the dosages of the local anesthetics being 
used to avoid toxicity leading to neurological and cardiac 
complications.
Opioid administration and patient‑controlled analgesia
Administration of opioids is considered a cornerstone of 
postoperative pain management; greater analgesic efficacy 
and higher patient satisfaction are achieved with opioid 
PCA.[26] PCA not only improves patient comfort but also 
it improves resource utilization.[27] Baltali[18] demonstrated 
that RM PCA was a better analgesic on the basis of pain 
scores during coughing and movement. Gurbet et al.[28] 
in a study, where they compared fentanyl, morphine, and 
RM, found that PCA of RM provided equal and adequate 
pain relief at rest after cardiac surgery such as morphine 
and fentanyl. Munro et al.[19] did not show significance 
difference in the use of PCA and NASC morphine. In 
a meta‑analysis comparing PCA with nurse‑controlled 
analgesia,[27] there was a 25% reduction in VAS scores 
for patients who used PCA compared to nurse‑controlled 
analgesia between 24 and 48 h postoperatively.
Ketamine
Ketamine has been used successfully for pain management 
in various trials.[29‑32] Lahtinen et al.[17] used S (+) ketamine 
as an analgesic adjunct and proved that it reduced opioid 
consumption in patients’ postcardiac surgery. Epidural 
S (+) ketamine was used effectively to reduce pain 
postknee arthroplasty when it was applied with ropivacaine 
in epidural anesthesia;[33] S (+) Ketamine was given as an 
infusion post knee arthroscopy,[34] and neither enhanced 
analgesia, nor provided opioid sparing effect. In Lahtinen 
et al.,[17] four patients developed transient hallucinations 
during the infusion versus none in the placebo group; 
however, opioid consumption in the S (+) Ketamine group 
decreased in the first 48 h.
Limitations to this study
Methodological quality of the randomized controlled trials 
in this systematic review varied. Due to the strict inclusion 
and exclusion criteria, the number of studies and ultimately 
patients for analysis was limited. Not all studies reported 
on all the outcome measures of interest to this study 
like complications, LOS. Despite these challenges, the 
information extracted was in line with previous studies, and 
the recommendations may lead to new and better ways of 
pain management in patients postcardiac surgery.
Conclusion
The use of PCA with opioids in conjunction with local 
subcutaneous anesthetic continuous infusions is much more 
effective longer. This approach might eventually be the 
cornerstone for pain management postcardiac surgery in 
ICUs. There is a need, therefore, for anesthetists and acute 
pain service teams to consider the use of mixed methods 
in pain management postcardiac surgery. There is a need 
to be cautious with Ketamine use postcardiac surgery until 
more dose‑related studies are done and concerns pertaining 
to psychotomimetic adverse reactions are addressed.
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